The role of antibody in the activation of the alternative complement pathway.
about
Infectious diseases associated with complement deficiencies.Complement system on the attack in autoimmunityMannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway.Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura.Meningococcal disease and the complement system.Surface epithelium related activation of complement differs in Crohn's disease and ulcerative colitis.Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeaeFactor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammationRoles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.Immunoglobulin G enhances C3 degradation on coagulase-negative staphylococci.Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysmLocal release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement.Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeaeEssential role of surface-bound complement factor H in controlling immune complex-induced arthritisVaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.Early complement components enhance neutralization of Chlamydia trachomatis infectivity by human sera.Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.Formation, clearance, deposition, pathogenicity, and identification of biopharmaceutical-related immune complexes: review and case studies.Antibody-mediated rejection despite inhibition of terminal complement.Complement in the pathophysiology and diagnosis of human diseases.Regulation of complement.Cercarial glycocalyx of Schistosoma mansoni activates human complement.Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells.Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodiesEvolution and diversity of the complement system of poikilothermic vertebrates.Host Soluble Mediators: Defying the Immunological Inertness of Aspergillus fumigatus Conidia.The influence of antibody functional affinity on the effector functions involved in the clearance of circulating immune complexes anti-BSA IgG/BSA.
P2860
Q30450183-03A89C1E-8562-4DFB-A428-5D6C4035E2F9Q33630290-9B1D027A-B8C3-4DB7-BDD2-1E24B46C0DC6Q33765773-AD2DDF4E-1459-4EA0-B058-8A16A3B28A38Q34207864-F75B06B3-22C1-47B4-B20B-C1D86008925CQ34376170-1148F715-C189-4B24-B115-22D862083C6EQ34395719-F2F6CBEC-2881-47FB-8B60-9C93FF23C4C8Q34558270-7A7C8E51-202E-484A-8C52-4C9DFD734DF3Q34563964-E5CE5D9C-CCDE-41A4-810D-29999D666E4AQ34650129-D721D947-6235-4F3D-AF3E-617113BFDE85Q34708606-0CF3E859-85A1-4ED1-A970-FC9DAD15A4E4Q35766497-6D2EFE89-BF9D-4747-AB3A-BC8A6F5908D7Q35782182-729647C9-1F78-4A17-A669-02C27DA2C730Q35787311-2ECE6902-C2D4-4EFE-9F07-CFF070824EAFQ36540594-2130A551-DAF4-45AE-8D82-3485D30324C2Q36633889-06D7599A-3B55-49BA-9913-0DD5861EAAD0Q36714001-3C66A5FD-1936-4696-BEE7-636EC6CAE6EFQ36791349-895B078F-64D1-4417-AB99-164E5821D0A8Q36946649-A0C31C5D-0407-46EE-99C4-48F3DBE3BB12Q37026600-D1200EF4-88C9-41DB-8A37-9540BCA16CFCQ37319631-BFA5A95A-4019-4FAD-891E-C2D6FCAC3333Q38202541-51BF45D1-07EA-4DB6-A3F5-3A8011806152Q38427447-23E6A468-6E0B-47BF-A427-BB975B6D2878Q39487716-CD594CDD-AE99-4524-9EA8-1A4B1248DDB5Q39628216-886D7364-0D24-41EE-9747-70BFF3E07A47Q40166109-733D7209-5CF8-4658-B933-DB2C4E9D8351Q41842699-6003C475-08EA-446C-AB87-205F8631F2B6Q41876336-1DD389BC-7D46-407B-AC23-1A6B4F82DF3CQ42120792-89CFBA34-B655-4438-BC32-D2D16B8412F3Q45161989-E75E8747-50BA-46B3-994D-E5462AAE55EDQ48163385-886FC84F-819B-48FE-A4DF-72A6BBE9692EQ50143117-EF0175B1-A2F8-48FF-9310-E2F53485C4CB
P2860
The role of antibody in the activation of the alternative complement pathway.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
The role of antibody in the activation of the alternative complement pathway.
@en
type
label
The role of antibody in the activation of the alternative complement pathway.
@en
prefLabel
The role of antibody in the activation of the alternative complement pathway.
@en
P2093
P2860
P356
P1476
The role of antibody in the activation of the alternative complement pathway.
@en
P2093
D T Fearon
K F Austen
W D Ratnoff
P2860
P2888
P304
P356
10.1007/BF02116280
P577
1983-01-01T00:00:00Z